youtube_live
Q3 2026 – zárobky • vydané • Výnos na akciu bol prekonaný +11,45% • Výnosy boli prekonané +3,01%
Zobraziť výsledkychevron_right
AMGN34:BVMF
Amgen Inc. BDR
93,78 BRL
0,00%
(0,00) 1 d.
4. 11., 17:39:47 GMT-3 · BRL
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre AMGN34…
Otvoriť
91,80 BRL
Vysoká
93,78 BRL
Nízka
91,80 BRL
Trh. kap.
258,68 mld.
Priem. obj.
423,00
Objem
30,00
Max. za 52 týž.
93,78 BRL
Min. za 52 týž.
47,76 BRL
Akcie v obehu
540,63 mil.
Počet zamestnancov
32 tis.
Otvoriť
91,80 BRL
Vysoká
93,78 BRL
Nízka
91,80 BRL
Trh. kap.
258,68 mld.
Priem. obj.
423,00
Objem
30,00
Max. za 52 týž.
93,78 BRL
Min. za 52 týž.
47,76 BRL
Akcie v obehu
540,63 mil.
Počet zamestnancov
32 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
GuruFocus
·
pred 9 hodinami
Amgen Inc (AMGN) Shares Surge 3.7% -- What GF Score of 85 Tells Investors
MarketWatch
·
pred 10 hodinami
Amgen Inc. stock underperforms Wednesday when compared to competitors despite daily gains
marketscreener.com
·
pred 14 hodinami
Amgen's Diversified Base Business Warrants Higher Multiple, UBS Says
Yahoo Finance
·
pred 15 hodinami
Amgen Stocks Rise 5.91% as Higher Guidance Narrows the Remaining Earnings Test
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Informácie o subjekte Amgen Inc. BDR
Generálny riaditeľRobert A. Bradway
Zamestnanci31,5 tis.
Dátum založenia1980
Hlavné sídloThousand Oaks, Kalifornia, Spojené štáty americké
Odvetvie-
Industry-
Webamgen.com